Contrary to its initial characterisation as primarily a respiratory disease, COVID-19 affects many organ systems, notably the cardiovascular system. From myocardial injury and thrombosis to arrhythmia and the emerging phenomenon of long COVID, COVID-19 remains a pervasive risk, not only for individuals with pre-existing cardiovascular diseases but also for those previously healthy, who may develop cardiovascular conditions as a consequence of the virus.

This month’s FOCUS provides carefully selected resources on the latest clinical research and best practices around COVID-19 and cardiovascular disease. Our mission is to create awareness, disseminate knowledge, and provide practical tools essential for navigating the complexities of managing COVID-19, including effective patient communication and continuous engagement with evolving research. Join us in this collaborative effort as we sharpen our focus on the dynamic interplay between COVID-19 and cardiovascular disease.

The content below, selected by Ronen Beeri, Yan Topilsky and Vanessa Lopes, will help you expand your knowledge of COVID-19.